» Articles » PMID: 2478524

Environmental Regulation of Expression of Virulence Determinants in Bordetella Pertussis

Overview
Journal J Bacteriol
Specialty Microbiology
Date 1989 Nov 1
PMID 2478524
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

The trans-activator vir is required for expression of all virulence-associated genes in Bordetella pertussis. The nature of the global regulation of these factors by vir and environmental signals was examined by Northern blot analysis and with beta-galactosidase transcriptional fusions in five vir-regulated genes. Northern blots suggested that vir regulates at the level of transcription since Vir- organisms did not exhibit detectable mRNA from vir-regulated loci. Environmental signals such as high levels of salts, nicotinic acid, and 6-chloronicotinic acid or growth at low temperatures were examined. Of all of the cations and anions examined, only SO4 ions eliminated transcription of vir-regulated genes and reduced transcription of vir itself, suggesting that global regulation is obtained by modifying expression of the essential component, vir. Organisms grown on 6-chloronicotinic acid or quinaldic acid did not have detectable transcription from vir-regulated loci. Modulation by nicotinic acid, on the other hand, was strain dependent, acting at the level of transcription in strain 18-323 but not in Tohama I derivatives. Growth at lower temperatures reduced, but did not eliminate, transcription from vir-regulated loci. At 28 degrees C the ratio of pertussis toxin mRNA to recA mRNA (a non-vir-regulated factor) was equivalent to that at 37 degrees C, suggesting that transcription at low temperatures is reduced in a proportional manner and need not involve vir.

Citing Articles

Lonidamine, a Novel Modulator for the BvgAS System of Bordetella Species.

Ota N, Nishida T, Standley D, Sherif A, Iwano S, Nugraha D Microbiol Immunol. 2024; 69(3):133-147.

PMID: 39674913 PMC: 11873758. DOI: 10.1111/1348-0421.13193.


Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with : Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria.

Tahar Djebbar K, Allouache M, Kezzal S, Benguerguoura F, TouilBoukoffa C, Zidi I Vaccines (Basel). 2022; 10(6).

PMID: 35746514 PMC: 9230502. DOI: 10.3390/vaccines10060906.


Pathogenicity and virulence of and its adaptation to its strictly human host.

Belcher T, Dubois V, Rivera-Millot A, Locht C, Jacob-Dubuisson F Virulence. 2021; 12(1):2608-2632.

PMID: 34590541 PMC: 8489951. DOI: 10.1080/21505594.2021.1980987.


Nanomotion Spectroscopy as a New Approach to Characterize Bacterial Virulence.

Villalba M, Venturelli L, Willaert R, Vela M, Yantorno O, Dietler G Microorganisms. 2021; 9(8).

PMID: 34442624 PMC: 8398272. DOI: 10.3390/microorganisms9081545.


A Mutation Upstream of the Ribosomal Operon Downregulates Bordetella pertussis Virulence Factor Production without Compromising Bacterial Survival within Human Macrophages.

Novak J, Jurnecka D, Linhartova I, Holubova J, Stanek O, Stipl D mSystems. 2020; 5(6).

PMID: 33293402 PMC: 7742992. DOI: 10.1128/mSystems.00612-20.


References
1.
STAINER D, Scholte M . A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol. 1970; 63(2):211-20. DOI: 10.1099/00221287-63-2-211. View

2.
Lacey B . Antigenic modulation of Bordetella pertussis. J Hyg (Lond). 1960; 58:57-93. PMC: 2134314. DOI: 10.1017/s0022172400038134. View

3.
Aiba H, Adhya S, de Crombrugghe B . Evidence for two functional gal promoters in intact Escherichia coli cells. J Biol Chem. 1981; 256(22):11905-10. View

4.
Schneider D, Parker C . Effect of pyridines on phenotypic properties of Bordetella pertussis. Infect Immun. 1982; 38(2):548-53. PMC: 347773. DOI: 10.1128/iai.38.2.548-553.1982. View

5.
McPheat W, Wardlaw A, Novotny P . Modulation of Bordetella pertussis by nicotinic acid. Infect Immun. 1983; 41(2):516-22. PMC: 264671. DOI: 10.1128/iai.41.2.516-522.1983. View